BLOOD DISORDERS Archives - Healthcare Communications Network

American Society of HematologyMarrow or Peripheral Blood for Allogeneic Transplant: Are We Ignoring the Data?

Despite peripheral blood making up 80% of all of hematopoietic cell transplants, there are similar rates of overall survival, disease-free survival, and transplant-related mortality when comparing marrow and peripheral blood as graft sources. Chronic graft-versus-host disease (GVHD) and cytokine release syndrome (CRS) are more significant in those who received peripheral blood, yet the standard of […]

Mayo ClinicA Case-Based Workshop: Clinical and Laboratory Aspects of Hemophilia and Thrombosis

In this symposium preceding the ASH Annual Meeting on 12/4/20, the overall objective is to inform participants about emerging diagnostic and therapeutic aspects of bleeding and thrombotic disorders. The speakers will illustrate how costly and unnecessary biochemical, phenotypic, and genetic testing can be avoided in the participants’ practices while enhancing highest quality medical care.

American Society of HematologyHow I Treat Unexplained Arterial Thrombosis

In this “How I Treat” feature from Blood, the authors conclude with three representative cases to both illustrate the application of the outlined diagnostic schema and discuss common management considerations, specifically the selection of anticoagulation vs. antiplatelet therapy for secondary prevention.

HMP CommunicationsIbrutinib May Improve Pulmonary Outcomes in Certain COVID-19 Cases

Although the findings reported in Blood should be considered as hypothesis-generating and preliminary in nature, a small clinical trial suggested ibrutinib may protect against lung injury and improve pulmonary function in hypoxic patients with COVID-19.